Introduction: In the pharmaceutical industry, crystalline forms such as polymorphs, salts, and cocrystals have long been the subject of IP protection. These solid forms can have different physical properties which impact the efficacy of drugs or the procedures for their preparation. For decades, companies have patented these forms to extend their market exclusivity. However, in […]
Navigating Patent Litigation: Paroxetine Read More »
We are thrilled to announce that Solitek has been invited by NANOMOL TECHNOLOGIES to participate in the prestigious Professional Workshop on Solid State Research in the Pharmaceutical Industry at FARMAFORUM 2024. This event will take place on September 26th in Madrid, bringing together leading experts to explore cutting-edge developments in the field. Our Operations Director
Solitek is thrilled to announce the renowned lineup of speakers for the upcoming “Unlocking Early Drug Development” symposium, taking place on November 5th, at the Parc Cientific de Barcelona, Spain. This one-day event is set to bring together some of the brightest minds in the pharmaceutical industry, offering a unique platform for knowledge exchange and
Solitek’s One Day Symposium: Unlocking Early Drug Development Symposium Read More »
Solitek is proud to announce that our co-founder, Víctor M. Díaz Pérez, has been invited to join the prestigious editorial boards of PharmaFocus Europe, PharmaFocus America, and PharmaFocus Asia. This invitation marks a significant milestone in Victor’s career and reflects his expertise and dedication to advancing the pharmaceutical industry. Víctor M. Díaz Pérez, who also
The path from drug discovery to clinical development is a exciting yet complex journey. In the changing landscape of pharmaceutical development, it’s crucial to identify drug candidates with the best chances of success. Particularly during early stages, when resources are limited, it’s important to effectively prioritize these candidates. This is where the refined Developability Classification
Preclinical Pharmaceutical Development: Streamlining the Pipeline Read More »
Barcelona, September 5th, 2023Solid Technologies SL (aka ‘Solitek’), a pioneering pharmaceutical and preclinical formulation development company, is thrilled to announce the establishment of its distinguished Advisory Board. Comprised of seasoned industry leaders, this esteemed panel of experts will bolster Solitek’s commitment to advancing pharmaceutical solutions and driving innovation in the field of preclinical development. The
We are excited to announce a new partnership with Agility Life Sciences.
An agreement designed to offer a larger portfolio of services to our clients.
Solitek forge Strategic Partnership with Agility Life Sciences Read More »
Patients may be missing out on innovative therapies. After having worked for many years in the design and development of novel active ingredients, this is a difficult fact to accept, but a fact, nevertheless.
Reflections on a Developability Assessment Program Read More »
AGQ labs and Solitek join forces in a commercial agreement for the distribution of analytical services and specialized advice in the development of solid forms. These services are of common application in the pharmaceutical sector, but their introduction in other industries, such as agrochemical or food supplements, can potentially bring significant advantages to the earlier implementers.
Abstract An approach to crystallization development is described, based on a mixture of theoretical modelling and experimentation that provides a deep understanding of the process factors that influence PSD and improves efficiency in development and … Introduction Nearly all synthetic steps in industrial chemical manufacturing end with a crystallization. This is because it is almost
Crystallization Development A – QbD Approach to PSD Control using Modelling Read More »
Charnwood Molecular, a leading UK-based pre-clinical discovery CRO serving the global pharmaceutical and biotechnology market, has added a range of new solid-state capabilities to its portfolio through a new collaborative partnership with Barcelona-based Solitek.
Welcome to a new concept in solid state development services that will help you bring innovative solutions to the market. Solitek brings a new concept in solid state development, combining an excellent understanding of the diversity of the solid form landscape exhibited by small molecule organic compounds with experience and practical know-how, increasing your chances
Solitek Sets up in the Scientific Park of Barcelona Read More »
Solitek: Delivering Solid Form Solutions with Decades of Expertise – Your Partner for Solid State and Preclinical Formulation Services.
Solid Technologies has participated in the ICEX-Next Export Initiation Program, and has had the support of ICEX, as well as the financing of European ERDF Funds, having contributed to the economic growth of this company, its region and Spain as a whole.
